| Literature DB >> 16675426 |
Tarmo Tiido1, Anna Rignell-Hydbom, Bo A G Jönsson, Yvonne Lundberg Giwercman, Henning S Pedersen, Bogdan Wojtyniak, Jan K Ludwicki, Vladimir Lesovoy, Valentyna Zvyezday, Marcello Spano, Gian-Carlo Manicardi, Davide Bizzaro, Eva C Bonefeld-Jørgensen, Gunnar Toft, Jens Peter Bonde, Lars Rylander, Lars Hagmar, Aleksander Giwercman.
Abstract
OBJECTIVE: Recent studies indicate that persistent organohalogen pollutants (POPs) may contribute to sex ratio changes in offspring of exposed populations. Our aim in the present study was to investigate whether exposure to 2,2 ,4,4 ,5,5 -hexachlorobiphenyl (PCB-153) and dichlorodiphenyldichloroethene (p,p -DDE) affects sperm Y:X chromosome distribution. SUBJECTS AND METHODS: We obtained semen and blood for analysis of PCB-153 and p,p -DDE levels from 547 men from Sweden, Greenland, Poland (Warsaw), and Ukraine (Kharkiv), with regionally different levels of POP exposure. The proportion of Y- and X-chromosome-bearing sperm in the semen samples was determined by two-color fluorescence in situ hybridization analysis.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16675426 PMCID: PMC1459925 DOI: 10.1289/ehp.8668
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Flow chart for recruitment of participants in semen and FISH study.
Characteristics of the study populations with respect to exposure and outcome variables, and potential confounders.
| Greenland ( | Sweden ( | Warsaw ( | Kharkiv ( | All ( | |
|---|---|---|---|---|---|
| Exposure variables | |||||
| PCB-153 (ng/g lipid) | |||||
| Median | 210 | 200 | 20 | 50 | 90 |
| Mean (95% CI) | 350 (270–430) | 260 (220–290) | 20 (18–24) | 55 (43–63) | 190 (160–220) |
| Median | 590 | 240 | 490 | 1,000 | 520 |
| Mean (95% CI) | 880 (690–1,100) | 350 (300–410) | 570 (520–640) | 1,300 (1,100–1,500) | 760 (680–840) |
| Potential confounders | |||||
| Age (years) | |||||
| Mean | 31 | 47 | 30 | 26 | 34 |
| Median (min–max) | 30 (18.5–51.3) | 48 (23.8–67.5) | 29 (24.1–46.3) | 24 (18.8–40.6) | 32 (18.5–67.5) |
| Current smoking (%) | 71.9 | 23.0 | 28.3 | 64.6 | 57.8 |
| Alcohol, > 21 drinks/week (%) | 6.2 | — | 2.4 | — | 2.2 |
| Period of abstinence (days) | |||||
| Mean | 5.7 | 3.7 | 6.9 | 4.1 | 4.9 |
| Median (min–max) | 3.0 (0.5–240) | 3.0 (0.5–15) | 3.5 (0.5–60) | 3.5 (0.5–11) | 3.0 (0.5–240) |
| Outcome variables | |||||
| Fraction of Y chromosomes (%) | |||||
| Mean | 51.2 | 51.2 | 50.3 | 50.7 | 50.9 |
| Median (min–max) | 50.8 (43.2–58.9) | 51.1 (47.5–56.7) | 50.3 (43.5–53.3) | 50.6 (47.1–58.2) | 50.7 (43.2–58.9) |
Abbreviations: —, not available; max, maximum; min, minimum.
Figure 2Distribution of PCB-153 (ng/g lipid) serum levels (A) and fraction of Y-bearing sperm in ejaculates (B) among men from different countries studied. Values shown are means and 95% CIs.
Crude proportions of Y-bearing spermatozoa according to serum concentrations of PCB-153 and study group.
| Greenland
| Sweden
| Warsaw
| Kharkiv
| |||||
|---|---|---|---|---|---|---|---|---|
| PCB-153 range (ng/g lipid) | No. | Mean (min–max) | No. | Mean (min–max) | No. | Mean (min–max) | No. | Mean (min–max) |
| 0–50 | 9 | 52.5 (49.2–58.8) | 20 | 50.3 (49.6–51.5) | 117 | 50.3 (48.1–53.2) | 68 | 50.7 (47.2–58.1) |
| > 50–100 | 20 | 51.1 (43.1–58.2) | 55 | 50.8 (47.5–55.3) | 3 | 49.0 (43.5–52.3) | 44 | 50.9 (47.2–55.5) |
| > 100–200 | 45 | 50.9 (48.1–55.2) | 52 | 51.1 (47.5–56.4) | 1 | 50.0 (50.1) | 7 | 50.1 (47.1–52.7) |
| > 200–400 | 42 | 51.5 (47.7–57.8) | 19 | 51.3 (47.6–55.2) | 0 | — | 0 | — |
| > 400 | 41 | 51.1 (48.9–56.7) | 3 | 51.6 (48.3–56.7) | 0 | — | 1 | 49.6 (49.6) |
Abbreviations: —, not applicable; max, maximum; min, minimum.
Crude proportions of Y-bearing spermatozoa according to serum concentrations of p,p′-DDE and study group.
| Greenland
| Sweden
| Warsaw
| Kharkiv
| |||||
|---|---|---|---|---|---|---|---|---|
| No. | Mean (min–max) | No. | Mean (min–max) | No. | Mean (min–max) | No. | Mean (min–max) | |
| 0–250 | 30 | 51.4 (43.1–58.8) | 79 | 50.7 (47.5–55.3) | 9 | 50.6 (48.9–51.9) | 0 | — |
| > 250–500 | 38 | 51.1 (48.1–55.2) | 40 | 52.1 (49.3–56.4) | 54 | 50.3 (48.1–52.4) | 8 | 50.2 (49.2–51.0) |
| > 500–1,000 | 40 | 51.4 (48.7–57.8) | 21 | 51.6 (49.2–55.5) | 49 | 50.1 (48.2–52.6) | 50 | 50.9 (47.2–58.1) |
| > 1,000– 1,500 | 23 | 50.7 (47.7–53.5) | 7 | 51.5 (48.3–56.7) | 5 | 51.1 (49.1–53.2) | 32 | 50.7 (48.8–53.6) |
| > 1,500 | 26 | 51.4 (48.9–56.7) | 2 | 50.7 (50.5–51.0) | 4 | 48.9 (43.5–51.4) | 30 | 50.5 (47.1–53.7) |
Abbreviations: —, not applicable; max, maximum; min, minimum.
Effect of PCB-153 (ng/g lipid) and p,p′-DDE (ng/g lipid) levels in serum (as continuous variable) on proportion of Y-bearing spermatozoa for men from the different populations.
| Percent of Y-sperm
| ||||
|---|---|---|---|---|
| Variables | No. | β | 95% CI (β) | |
| Ln[PCB-153] | ||||
| Greenland | 157 | 0.03 | 0.83 | −0.33 to 0.41 |
| Sweden | 149 | 0.53 | 0.04 | 0.001 to 1.05 |
| Warsaw | 121 | −0.54 | 0.008 | −0.92 to −0.14 |
| Kharkiv | 120 | 0.23 | 0.27 | −0.18 to 0.64 |
| Ln[ | ||||
| Greenland | 157 | 0.07 | 0.65 | −0.25 to 0.41 |
| Sweden | 149 | 0.75 | < 0.001 | 0.35 to 1.15 |
| Warsaw | 121 | −0.35 | 0.20 | −0.89 to 0.19 |
| Kharkiv | 120 | −0.15 | 0.54 | −0.64 to 0.34 |
The data were obtained from multiple regression analyses. If the adjusted estimate differed < 10% from the crude estimate, only the crude results are presented. Confounder-adjusted estimated effects (β):
age;
abstinence;
current smoking;
alcohol consumption.
Effect of PCB-153 (ng/g lipid) and p,p′-DDE (ng/g lipid) levels in serum in lowest versus highest category on proportion of Y-bearing spermatozoa for men from the different populations.
| Percent of Y-sperm
| ||||
|---|---|---|---|---|
| Variables | No. | β | 95% CI (β) | |
| Ln[PCB-153] | ||||
| Greenland | 157 | −0.95 | 0.227 | −2.51 to 0.60 |
| Sweden | 149 | 1.56 | 0.192 | −0.68 to 3.82 |
| Warsaw | 121 | NA | — | — |
| Kharkiv | 120 | NA | — | — |
| Ln[ | ||||
| Greenland | 157 | 0.42 | 0.477 | −0.75 to 1.61 |
| Sweden | 149 | 0.03 | 0.980 | −2.31 to 2.36 |
| Warsaw | 121 | −1.47 | 0.064 | −3.04 to 0.08 |
| Kharkiv | 120 | NA | — | — |
—, not available; NA, not analyzed because data were not available. The data were obtained from multiple regression analyses. If the adjusted estimate differed < 10% from the crude estimate, only the crude results are presented. Confounder-adjusted estimated effects (β):
age;
abstinence;
current smoking;
alcohol consumption.